Skip to main content

Day: April 9, 2020

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biologics contract manufacturing organization and biotechnology innovator, today announced the signing of two Master Services Agreements (the MSAs”) and a Memorandum of Understanding (the “MoU”) with the Infectious Disease Research Institute (“IDRI”) in support of iBio’s SARS-CoV-2 Virus-Like Particle (“VLP”) vaccine development.Under the MSAs, IDRI will support pre-clinical development and provide clinical trial oversight, while iBio will provide process development and manufacturing services to IDRI, as needed. Additionally, the MoU calls for iBio and IDRI to establish a separate, additional agreement within the next 60 days if the Company opts to include one of IDRI’s novel adjuvants in the COVID-19 vaccine development program...

Continue reading

VitalHub Announces Availability of MCAP Lite – Rapid Assessment for Discharge Readiness (RADR) Solution for Hospitals Globally

TORONTO, April 09, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) in response to the pandemic and to support hospitals that need to increase capacity, is making available at no cost, access to a lite version of our Making Care Appropriate for Patients (MCAP) solution and associated evidence-based clinical criteria through it’s Rapid Assessment for Discharge Readiness (RADR) solution.RADR is a derivative of MCAP, the #1 ranked patient flow solution based on combined quality and value scores in the NHS England’s Clinical Utilisation Review framework.MCAP is an internationally validated solution that’s been used in North America, Europe, Australia and the Middle East, including at more than >160 hospitals in the UK to identify patient flow improvement opportunities.The RADR solution is being provided...

Continue reading

MPX INTERNATIONAL ANNOUNCES VIRTUAL CONSULTATION TO SUPPORT MEDICAL CANNABIS PATIENTS DURING COVID-19

NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS.TORONTO, April 09, 2020 (GLOBE NEWSWIRE) — MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (CSE:MPXI; OTCQX:MPXOF), a multinational diversified cannabis company, announces that it has expanded its virtual medical services to ALL Canadians through the Spartan Wellness portal on the Medical Cannabis Learning Network (the “MCLN”) which can be accessed by visiting https://portal.mcln.tv.“With the most recent world events, we are pleased that we are equipped, through our Spartan Wellness Clinic and the Medical Cannabis Learning Network, to offer virtual consultations and medical cannabis choices to...

Continue reading

FirstService Announces Election of Directors

TORONTO, April 09, 2020 (GLOBE NEWSWIRE) — FirstService Corporation (TSX: FSV) (NASDAQ: FSV) (“FirstService”) today announced that at its annual meeting of shareholders, held in Toronto yesterday, the eight director nominees listed in FirstService’s management information circular dated February 28, 2020, as supplemented (the “Circular”), were elected as directors of FirstService. Directors have been elected to serve until the close of the next annual meeting of shareholders. The detailed results of the vote are set out below.*      The number of votes disclosed reflects proxies received by management in advance of the meeting.FirstService shareholders also approved the appointment of PricewaterhouseCoopers LLP as the auditor of FirstService for the ensuing year and a non-binding advisory resolution on FirstService’s approach to...

Continue reading

Dundee Precious Metals Delivers Another Strong Operational Quarter; Announces First Quarter 2020 Preliminary Production Results

TORONTO, April 09, 2020 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announced strong preliminary production results from both of its mines and smelter for the three months ended March 31, 2020. The Company is on track to meet its previously issued guidance for 2020 at each of its operations.“DPM delivered exceptional first quarter production results at each of our three operations for a strong start to the year,” said Rick Howes, President and CEO. “We continue to manage the evolving COVID-19 situation by prioritizing the health and safety of our workforce and local communities as well as striving to maintain the continuity of our operations.”Production HighlightsPreliminary results for the first quarter are provided in the table below:(1)    As disclosed in Management’s Discussion and Analysis...

Continue reading

The Movie Studio Executes MOU to Acquire Ott Platform, Apps and Assets of BINGE Networks

FORT LAUDERDALE, Fla., April 09, 2020 (GLOBE NEWSWIRE) — via NetworkWire – The Movie Studio Inc. (OTC: MVES) (the “Company”), a vertically integrated motion picture production company, today announces it has executed a memorandum of understanding (MOU) to acquire BINGE Networks, LLC. Both parties are conducting due diligence and in the near future seek to complete their transaction and enter into a Letter of Intent (LOI).BINGE Networks (www.bingenetworks.tv) is an award-winning streaming media platform, recipient of the Most Innovative Media Content Monetizing & Streaming Platform CV-Magazine-USA 2019 and New York 2019 Award Programing. The BINGE App is built into over 100 smart TV networks, providing the ability to globally and instantly syndicate and monetize content through key strategic partnerships throughout the streaming...

Continue reading

Aravive Announces Board Composition and Executive Management Transitions

Healthcare Entrepreneur Fred Eshelman, Pharm.D., Appointed Board ChairmanAravive’s Chief Scientific Officer, Gail McIntyre, Ph.D., Appointed CEOAravive to Host Conference Call Today at 9:00 AM ETHOUSTON, April 09, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced transitions in its board of directors and executive team, effective immediately. Fred Eshelman, Pharm.D., has been unanimously appointed to the board of directors and named chairman of the board. Jay Shepard, Srinivas Akkaraju, M.D., Ph.D., and Robert Hoffman have resigned from the board of directors. Rekha Hemrajani has resigned as the company’s chief executive officer and as a director. Gail McIntyre, Ph.D., the company’s chief scientific officer, has been named chief executive officer of Aravive and appointed...

Continue reading

Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicians

ALPHARETTA, Ga., April 09, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today the formation of a Scientific Advisory Board comprised of world-renowned retinal physicians to advise on the Company’s research and development programs. “Over the past year, we have been building awareness around the potential benefits of targeting treatment in the suprachoroidal space and working closely with retinal specialists to present data on this novel approach. These efforts have led to the formation of a group of leading retinal physicians who can provide real-world insights and validate the scientific rationale for our expanding pipeline programs. We are...

Continue reading

Calibre Mining Announces Drilling Results From the Panteon Deposit at El Limon, including 17.77 g/t Au over 10.8 metres

VANCOUVER, British Columbia, April 09, 2020 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) is pleased to report drilling results from the Panteon deposit, part of the El Limon mine complex. The drilling results confirm the continuity of high-grade gold mineralization over consistent, mineable widths along the down-plunge projection of the deposit, below the base of historic workings.Prior to the start of drilling in Q4 2019, the deposit had only been tested 120 metres along strike and to a depth of 115 metres from surface. The current drilling is focused on delineating an indicated resource along the down plunge projection of the deposit, as well as to test potential at depth and along strike to the southeast (see link to figures below).Highlighted drill results from the Panteon drilling...

Continue reading

Pennexx’s “Your Social Offers” is Poised to Help Businesses Attract New Customers

Clearwater, FL, April 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Pennexx Foods (OTC:PNNX): Earlier this week, Pennexx launched its Your Social Offers (YSO) portal to the public at http://yoursocialoffers.com that allows businesses to register and create a rewards campaign that can grow virally on Facebook.To get the reward, consumers share the reward on Facebook which then allows their friends to also get the benefit by sharing the reward to their own followers. Vincent Risalvato, CEO Pennexx, said, “I believe that this product can be used to enlighten the public of stores which are open for pickup and delivery during this trying time and I am very excited to help businesses regain business and grow.”What gives this business such great growth potential is that people want to save money and businesses want to grow. This makes...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.